Cimpress plc [CMPR] vs Dolby Laboratories [DLB] Detailed Stock Comparison

Cimpress plc

NASDAQ
Loading...

Dolby Laboratories Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Cimpress plc wins in 6 metrics, Dolby Laboratories Inc. wins in 14 metrics, with 0 ties. Dolby Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cimpress plc Dolby Laboratories Inc. Better
P/E Ratio (TTM) 84.69 26.28 Dolby Laboratories Inc.
Price-to-Book Ratio -3.82 2.39 Dolby Laboratories Inc.
Debt-to-Equity Ratio -3.34 1.56 Dolby Laboratories Inc.
PEG Ratio -4.72 -1.24 Dolby Laboratories Inc.
EV/EBITDA 10.58 15.70 Cimpress plc
Profit Margin (TTM) 0.66% 17.97% Dolby Laboratories Inc.
Operating Margin (TTM) 8.58% 20.95% Dolby Laboratories Inc.
EBITDA Margin (TTM) 8.58% 20.95% Dolby Laboratories Inc.
Return on Equity -2.65% 9.46% Dolby Laboratories Inc.
Return on Assets (TTM) 7.79% 5.26% Cimpress plc
Free Cash Flow (TTM) $144.95M $430.26M Dolby Laboratories Inc.
Dividend Yield N/A 2.07% N/A
1-Year Return 122.68% -24.85% Cimpress plc
Price-to-Sales Ratio (TTM) 0.57 4.63 Cimpress plc
Enterprise Value $3.50B $5.61B Dolby Laboratories Inc.
EV/Revenue Ratio 0.98 4.19 Cimpress plc
Gross Profit Margin (TTM) 46.80% 87.54% Dolby Laboratories Inc.
Revenue per Share (TTM) $144 $14 Cimpress plc
Earnings per Share (Diluted) $0.98 $2.47 Dolby Laboratories Inc.
Beta (Stock Volatility) 1.71 0.86 Dolby Laboratories Inc.
Short % of Float 12.36% 8.57% Dolby Laboratories Inc.

Cimpress plc vs Dolby Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

CMPR
DLB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cimpress plc-1.25%-6.55%2.70%36.67%38.03%48.10%
Dolby Laboratories Inc.-1.29%-1.66%-4.79%-14.60%-16.14%-12.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cimpress plc122.68%93.10%2.23%-0.69%104.52%199.57%
Dolby Laboratories Inc.-24.85%-33.11%-42.48%16.64%22.44%147.28%

Performance & Financial Health Analysis: Cimpress plc vs Dolby Laboratories Inc.

MetricCMPRDLB
Market Information
Market Cap i$2.01B$6.02B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i106,019537,010
90 Day Avg. Volume i124,756611,700
Last Close$96.02$54.89
52 Week Range$42.05 - $106.13$52.45 - $77.00
% from 52W High-9.53%-28.71%
All-Time High$171.76 (Mar 05, 2018)$104.74 (May 03, 2021)
% from All-Time High-44.10%-47.59%
Growth Metrics
Quarterly Revenue Growth0.11%-0.03%
Quarterly Earnings Growth-0.19%-0.21%
Financial Health
Profit Margin (TTM) i0.01%0.18%
Operating Margin (TTM) i0.09%0.21%
Return on Equity (TTM) i-0.03%0.09%
Debt to Equity (MRQ) i-3.341.56
Cash & Liquidity
Book Value per Share (MRQ)$-21.74$27.15
Cash per Share (MRQ)$10.63$6.75
Operating Cash Flow (TTM) i$306.89M$420.22M
Levered Free Cash Flow (TTM) i$184.59M$367.37M
Dividends
Last 12-Month Dividend Yield iN/A2.07%
Last 12-Month Dividend iN/A$1.38

Valuation & Enterprise Metrics Analysis: Cimpress plc vs Dolby Laboratories Inc.

MetricCMPR (Apr 24, 2026)DLB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i84.6926.28
Forward P/E i14.7414.01
PEG Ratio i-4.72-1.24
Price to Sales (TTM) i0.574.63
Price to Book (MRQ) i-3.822.39
Market Capitalization
Market Capitalization i$2.01B$6.02B
Enterprise Value i$3.50B$5.61B
Enterprise Value Metrics
Enterprise to Revenue i0.984.19
Enterprise to EBITDA i10.5815.70
Risk & Other Metrics
Beta i1.710.86
Book Value per Share (MRQ) i$-21.74$27.15

Financial Statements Comparison: Cimpress plc vs Dolby Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCMPR (2025)DLB (2025)
Revenue/Sales i3.40B1.35B
Cost of Goods Sold i1.79B160.13M
COGS % of Revenue i52.5%11.9%
Gross Profit i1.62B1.19B
Gross Margin i47.5%88.1%
Research & Development i334.04M261.79M
Operating Income (EBIT) i231.80M279.97M
Operating Margin i6.8%20.8%
EBITDA i373.28M393.57M
EBITDA Margin i11.0%29.2%
Pre-Tax Income i96.96M303.49M
Pre-Tax Income % of Revenue i2.8%22.5%
Income Tax i84.11M46.99M
Income Tax % of Revenue i2.5%3.5%
Net Income (Profit) i12.85M256.49M
Profit Margin i0.4%19.0%

Balance Sheet & Liquidity Metrics

MetricCMPR (2025)DLB (2025)
Cash & Equivalents i233.98M701.89M
Total Current Assets i502.61M1.39B
Total Current Assets % of Revenue i14.8%102.9%
Total Current Liabilities i758.66M437.79M
Total Current Liabilities % of Revenue i22.3%32.4%
Long-Term Debt i1.67B28.49M
Long-Term Debt % of Revenue i49.0%2.1%
Total Shareholders Equity i-563.45M2.63B
Retained Earnings i225.12M2.63B
Retained Earnings % of Revenue i6.6%195.3%
Property, Plant & Equipment i83.95M267.63M

Cash Flow Statement Comparison

MetricCMPR (2025)DLB (2025)
Operating Cash Flow i243.50M432.40M
Operating Cash Flow % of Revenue i7.2%32.1%
Capital Expenditures i-89.02M-36.35M
Free Cash Flow i144.95M430.26M
FCF Margin i4.3%31.9%
Debt Repayment i-587.87MN/A
Common Stock Repurchase i-77.78M-162.23M

Short Interest & Institutional Ownership Analysis

MetricCMPRDLB
Shares Short i1.85M3.91M
Short Ratio i16.046.02
Short % of Float i12.36%8.57%
Shares Outstanding i24.41M95.53M
Float Shares i13.67M60.20M
% Held by Insiders i16.65%1.28%
% Held by Institutions i91.49%99.28%
% Held by Public i-8.14%-0.56%

Dividend Analysis & Yield Comparison: Cimpress plc vs Dolby Laboratories Inc.

MetricCMPRDLB
Last 12-Month Dividend iN/A$1.38
Last 12-Month Dividend Yield iN/A2.07%
3-Year Avg Annual Dividend iN/A$1.26
3-Year Avg Dividend Yield iN/A0.41%
3-Year Total Dividends iN/A$3.78
Ex-Dividend DateN/AFeb 10, 2026